Dri Capital

DRI Capital, based in Toronto, ON, is a pioneer in pharmaceutical royalty monetization. They focus on building a diversified portfolio of interests in medicines that effectively treat and address unmet medical needs, actively sourcing royalty streams on medically necessary products with long-term patent protection and high growth potential.

As a smart capital allocator, DRI Capital acquires dependable, patent-protected cash flow streams derived from the sales of important drugs across multiple therapeutic areas. They offer tailored, best-in-class partnerships for investors and innovators, providing unique, creative, and flexible structures to meet counterparty needs.

Investors benefit from uniquely favorable exposure through DRI Capital's diversified, risk-mitigated portfolio of therapeutic assets, aiming to generate attractive returns and significant growth potential. With offices in Toronto and New Jersey, DRI Capital is committed to driving value creation in the pharmaceutical industry.

Generated from the website content